• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面半胱氨酸可以保护 SARS-CoV-2 主蛋白酶免受氧化损伤。

Surface cysteines could protect the SARS-CoV-2 main protease from oxidative damage.

机构信息

Beckman Institute, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA.

Beckman Institute, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA.

出版信息

J Inorg Biochem. 2022 Sep;234:111886. doi: 10.1016/j.jinorgbio.2022.111886. Epub 2022 Jun 2.

DOI:10.1016/j.jinorgbio.2022.111886
PMID:35675741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9161685/
Abstract

The SARS-CoV-2 main protease (M) is responsible for cleaving twelve nonstructural proteins from the viral polyprotein. M, a cysteine protease, is characterized by a large number of noncatalytic cysteine (Cys) residues, none involved in disulfide bonds. In the absence of a tertiary-structure stabilizing role for these residues, a possible alternative is that they are involved in redox processes. We report experimental work in support of a proposal that surface cysteines on M can protect the active-site Cys145 from oxidation by reactive oxygen species (ROS). In investigations of enzyme kinetics, we found that mutating three surface cysteines to serines did not greatly affect activity, which in turn indicates that these cysteines could protect Cys145 from oxidative damage.

摘要

严重急性呼吸综合征冠状病毒 2 主蛋白酶(M)负责从病毒多蛋白中切割出 12 种非结构蛋白。M 是一种半胱氨酸蛋白酶,其特征是含有大量非催化半胱氨酸(Cys)残基,没有一个参与二硫键的形成。在这些残基没有稳定三级结构的作用的情况下,它们可能参与氧化还原过程。我们报告了支持以下假设的实验工作,即 M 上的表面半胱氨酸可以保护活性位点 Cys145 不被活性氧(ROS)氧化。在对酶动力学的研究中,我们发现将三个表面半胱氨酸突变为丝氨酸并没有大大影响活性,这反过来表明这些半胱氨酸可以保护 Cys145 免受氧化损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8d/9161685/f86b53d9d07d/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8d/9161685/9aca0aa7843f/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8d/9161685/3212c89aa8ff/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8d/9161685/f0c6c86fcf6d/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8d/9161685/460b71063ed1/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8d/9161685/f86b53d9d07d/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8d/9161685/9aca0aa7843f/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8d/9161685/3212c89aa8ff/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8d/9161685/f0c6c86fcf6d/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8d/9161685/460b71063ed1/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8d/9161685/f86b53d9d07d/gr4_lrg.jpg

相似文献

1
Surface cysteines could protect the SARS-CoV-2 main protease from oxidative damage.表面半胱氨酸可以保护 SARS-CoV-2 主蛋白酶免受氧化损伤。
J Inorg Biochem. 2022 Sep;234:111886. doi: 10.1016/j.jinorgbio.2022.111886. Epub 2022 Jun 2.
2
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300.通过半胱氨酸 300 的谷胱甘肽化实现对 SARS-CoV-2 主要蛋白酶的二聚化和活性的调节。
mBio. 2021 Aug 31;12(4):e0209421. doi: 10.1128/mBio.02094-21. Epub 2021 Aug 17.
3
Kinetic comparison of all eleven viral polyprotein cleavage site processing events by SARS-CoV-2 main protease using a linked protein FRET platform.利用连接蛋白荧光共振能转移平台对 SARS-CoV-2 主蛋白酶的所有 11 种病毒多蛋白切割位点加工事件进行动力学比较。
J Biol Chem. 2024 Jun;300(6):107367. doi: 10.1016/j.jbc.2024.107367. Epub 2024 May 15.
4
Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.泛 3C 蛋白酶抑制剂鲁匹那韦以独特的结合模式结合 SARS-CoV-2 主蛋白酶。
Biochemistry. 2021 Oct 5;60(39):2925-2931. doi: 10.1021/acs.biochem.1c00414. Epub 2021 Sep 10.
5
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188.SARS-CoV-2 主蛋白酶与非共价抑制剂 ML188 复合物的晶体结构
Viruses. 2021 Jan 25;13(2):174. doi: 10.3390/v13020174.
6
2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.2-吡啶酮类天然产物作为 SARS-CoV-2 主蛋白酶抑制剂。
Chem Biol Interact. 2021 Feb 1;335:109348. doi: 10.1016/j.cbi.2020.109348. Epub 2020 Dec 2.
7
A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors*.一种快速获得多种高活性 SARS-CoV-2 主蛋白酶抑制剂的方法*。
ChemMedChem. 2021 Mar 18;16(6):942-948. doi: 10.1002/cmdc.202000924. Epub 2020 Dec 10.
8
Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface.基于配体的虚拟筛选和小分子盲对接揭示了 SARS-CoV-2 主蛋白酶二聚体界面上的一个可能的靶位。
Comput Biol Chem. 2020 Dec;89:107372. doi: 10.1016/j.compbiolchem.2020.107372. Epub 2020 Sep 5.
9
Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease.计算引导鉴定柑橘类黄酮作为 SARS-CoV-2 主蛋白酶潜在抑制剂
Mol Divers. 2021 Aug;25(3):1745-1759. doi: 10.1007/s11030-020-10150-x. Epub 2020 Nov 25.
10
Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV-2 Main Protease.基于结构的虚拟筛选发现新型 SARS-CoV-2 主蛋白酶抑制剂
J Chem Inf Model. 2020 Dec 28;60(12):5781-5793. doi: 10.1021/acs.jcim.0c00546. Epub 2020 Aug 4.

引用本文的文献

1
Covalent adduction of serotonin-derived quinones to the SARS-CoV-2 main protease expressed in a cultured cell.血清素衍生的醌与在培养细胞中表达的 SARS-CoV-2 主蛋白酶的共价加合。
Free Radic Biol Med. 2023 Sep;206:74-82. doi: 10.1016/j.freeradbiomed.2023.06.018. Epub 2023 Jun 28.
2
How the Competition for Cysteine May Promote Infection of SARS-CoV-2 by Triggering Oxidative Stress.半胱氨酸竞争如何通过引发氧化应激促进新冠病毒感染
Antioxidants (Basel). 2023 Feb 14;12(2):483. doi: 10.3390/antiox12020483.
3
Regulation of Retroviral and SARS-CoV-2 Protease Dimerization and Activity through Reversible Oxidation.

本文引用的文献

1
Structural and functional significance of the amino acid differences ValThr, SerAla, AsnSer, and AlaSer in 3C-like proteinases from SARS-CoV-2 and SARS-CoV.SARS-CoV-2 和 SARS 冠状病毒 3C 样蛋白酶中氨基酸差异 ValThr、SerAla、AsnSer 和 AlaSer 的结构和功能意义。
Int J Biol Macromol. 2021 Dec 15;193(Pt B):2113-2120. doi: 10.1016/j.ijbiomac.2021.11.043. Epub 2021 Nov 11.
2
Allosteric inhibition of SARS-CoV-2 3CL protease by colloidal bismuth subcitrate.枸橼酸铋胶体对严重急性呼吸综合征冠状病毒2 3CL蛋白酶的变构抑制作用
Chem Sci. 2021 Sep 24;12(42):14098-14102. doi: 10.1039/d1sc03526f. eCollection 2021 Nov 3.
3
通过可逆氧化调控逆转录病毒和SARS-CoV-2蛋白酶的二聚化及活性
Antioxidants (Basel). 2022 Oct 18;11(10):2054. doi: 10.3390/antiox11102054.
The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors.
SARS-CoV-2 主蛋白酶的二聚体-单体平衡受小分子抑制剂影响。
Sci Rep. 2021 Apr 29;11(1):9283. doi: 10.1038/s41598-021-88630-9.
4
Structural leitmotif and functional variations of the structural catalytic core in (chymo)trypsin-like serine/cysteine fold proteinases.(糜)胰蛋白酶样丝氨酸/半胱氨酸折叠蛋白酶的结构催化核心的结构主题和功能变化。
Int J Biol Macromol. 2021 May 15;179:601-609. doi: 10.1016/j.ijbiomac.2021.03.042. Epub 2021 Mar 10.
5
SARS-CoV-2 M inhibitors with antiviral activity in a transgenic mouse model.具有抗病毒活性的 SARS-CoV-2 M 抑制剂在转基因小鼠模型中。
Science. 2021 Mar 26;371(6536):1374-1378. doi: 10.1126/science.abf1611. Epub 2021 Feb 18.
6
Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2.新型冠状病毒 SARS-CoV-2 主蛋白酶(3CLpro)的生化和生物物理特性分析。
Sci Rep. 2020 Dec 17;10(1):22200. doi: 10.1038/s41598-020-79357-0.
7
SARS-CoV-2 M inhibitors and activity-based probes for patient-sample imaging.SARS-CoV-2 M 抑制剂和基于活性的探针用于患者样本成像。
Nat Chem Biol. 2021 Feb;17(2):222-228. doi: 10.1038/s41589-020-00689-z. Epub 2020 Oct 22.
8
Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography.中子晶体学揭示 SARS-CoV-2 主蛋白酶的非寻常两性离子催化位点。
J Biol Chem. 2020 Dec 11;295(50):17365-17373. doi: 10.1074/jbc.AC120.016154. Epub 2020 Oct 15.
9
Structural stability of the SARS-CoV-2 main protease: Can metal ions affect function?SARS-CoV-2 主要蛋白酶的结构稳定性:金属离子会影响其功能吗?
J Inorg Biochem. 2020 Oct;211:111179. doi: 10.1016/j.jinorgbio.2020.111179. Epub 2020 Jul 16.
10
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.SARS-CoV-2 主蛋白酶的晶体结构为设计改良的 α-酮酰胺抑制剂提供了基础。
Science. 2020 Apr 24;368(6489):409-412. doi: 10.1126/science.abb3405. Epub 2020 Mar 20.